WolverHeme Happy Hour

By: Bernard Marini Anthony Perissinotti et al.
Listen for free

  • Summary

  • Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
    Bernard Marini, Anthony Perissinotti, et al.
    Show more Show less
activate_WEBCRO358_DT_T2
Episodes
  • Houston, we don't have a problem... with APOLLO

    Houston, we don't have a problem... with APOLLO
    Aug 28 2024

    In this episode, Anthony and Bernie discuss the recently reported APOLLO trial in high-risk APL and debate whether this should represent the new standard of care in this population. We also review key practical considerations for the treatment of APL patients, including side effect management and treatment of APL in unique clinical scenarios.


    APOLLO: https://library.ehaweb.org/eha/2024/eha2024-congress/422206/uwe.platzbecker.first.results.of.the.apollo.trial.a.randomized.phase.iii.study.html
    Show more Show less
    59 mins
  • From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment

    From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment
    Jun 13 2024

    In this episode, Bernie and Anthony review the full history of APL treatment, in preparation for the upcoming plenary presentation of the APOLLO study THIS WEEKEND at EHA 2024!


    How did we get to our current standard of care in APL? How and why did the PETHEMA, GIMEMA, UK MRC, and other cooperative group regimens evolve over time into what they are today?


    And importantly, is the APOLLO control arm (no arsenic!), ok? Tune in to find out!

    Show more Show less
    58 mins
  • Episode 24: Myeloma Madness with the Myeloma Man

    Episode 24: Myeloma Madness with the Myeloma Man
    Apr 17 2024

    In this episode, Anthony and Bernie are joined by Multiple Myeloma expert Dr. Manni Mohyuddin, to discuss the recent FDA approval updates of CAR-T in this disease state. We also discuss the hotly debated topic of MRD as a surrogate endpoint for accelerated approval in Myeloma.

    Show more Show less
    59 mins
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about WolverHeme Happy Hour

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available